Cartesian Therapeutics, Inc.
RNAC$222M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaFREDERICK66 employees
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Nov 30, 2026
37wMarket Overview
Stock performance and key metrics
RNAC News
Catalyst Timeline
2 upcoming, 1 past
Drug Pipeline
Decartes-08
Myasthaenia Gravis
Descartes-08
Systemic Lupus Erythematosus (SLE)
Descartes 11
Multiple Myeloma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Decartes-08 | Phase 3 | Myasthaenia Gravis | - | - |
Descartes-08 | Phase 2 | Systemic Lupus Erythematosus (SLE) | - | - |
Descartes 11 | Phase 2 | Multiple Myeloma | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply